Description
NANOSPHERE VERIGENE REAGENTS - OPTION YEAR 3
First action · last action
2018-10-01 · 2020-03-12
Transactions
3
First transaction's obligation
$78,880
Base + all options value (sum of deltas)
$48,385
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA25815D0081
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2018-10-01+$78,880= $78,880
- Mod P000012019-10-29-$15,000= $63,880
- Mod P000022020-03-12-$15,495= $48,385
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2018-10-01 | +$78,880 | $78,880 | NANOSPHERE VERIGENE REAGENTS - OPTION YEAR 3 |
| Mod P00001· FUNDING ONLY ACTION | 2019-10-29 | −$15,000 | $63,880 | NANOSPHERE VERIGENE REAGENTS - OPTION YEAR 3 |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-03-12 | −$15,495 | $48,385 | NANOSPHERE VERIGENE REAGENTS - OPTION YEAR 3 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI DNQ4H6RCTMJ5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26220N0113 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $74,577 | FY2020 |
| 36C25919N0012 | NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $80,000 | FY2019 |
| 36C25918N1818 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $20,599 | FY2018 |
| 36C26018P0854 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $47,945 | FY2018 |
| 36C24418P0693 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $80,066 | FY2018 |
| 36C25918N0089 | NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $80,000 | FY2018 |
Other recipients under 6505 from 262-NETWORK CONTRACT OFFICE 22 (36C262) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26226N0873 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $140,823 | FY2026 |
| 36C26226N0871 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $231,746 | FY2026 |
| 36C26226N0870 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $167,369 | FY2026 |
| 36C26226N0872 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $164,265 | FY2026 |
| 36C26226P1412 | ASD SPECIALTY HEALTHCARE, LLC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $38,220 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26219N0189_3600_VA25815D0081_3600 · retrieved 2026-09-26.